NCT05122598View on ClinicalTrials.gov

Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 30, 2023

Conditions
Mild Cognitive ImpairmentEarly Alzheimer's DiseaseMemory Impairment
Interventions
DRUG

COT

The COT with proprietary odorant molecules is designed to stimulate olfactory neural activity over long periods of time combined with orbitofrontal cortex (OFC) dependent olfactory tasks.

DRUG

Sham

Sham COT uses artificially scented compressed room air instead of olfactory stimulants and has control cognitive olfactory tasks.

Trial Locations (3)

20002

RECRUITING

Clinics of Dr. Edwin Chapman @ MHDG, Washington D.C.

20020

RECRUITING

Family and Medical Counseling Service, Inc, Washington D.C.

20060

RECRUITING

Howard University (HU), Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Howard University

OTHER

collaborator

Family and Medical Counseling Service, Inc

UNKNOWN

collaborator

Medical Home Development Group

UNKNOWN

collaborator

National Institute on Aging (NIA)

NIH

collaborator

Johns Hopkins University

OTHER

lead

Evon Medics LLC

INDUSTRY

NCT05122598 - Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter